Drug Information

Drug General Information
Drug ID
D0FD6Z
Former ID
DNC005579
Drug Name
8-Fluoro-6-(4-hydroxy-phenyl)-naphthalen-2-ol
Drug Type
Small molecular drug
Indication Discovery agent Investigative [527584]
Structure
Download
2D MOL

3D MOL
Formula
C16H11FO2
Canonical SMILES
C1=CC(=CC=C1C2=CC(=C3C=C(C=CC3=C2)O)F)O
InChI
1S/C16H11FO2/c17-16-8-12(10-1-4-13(18)5-2-10)7-11-3-6-14(19)9-15(11)16/h1-9,18-19H
InChIKey
KBQSRNQTSRTYGN-UHFFFAOYSA-N
PubChem Compound ID
10308090
Target and Pathway
Target(s) Estrogen receptor Target Info Inhibitor [527584]
Estrogen receptor beta Target Info Inhibitor [527584]
KEGG Pathway Estrogen signaling pathway
Prolactin signaling pathway
Thyroid hormone signaling pathway
Endocrine and other factor-regulated calcium reabsorption
Proteoglycans in cancerhsa04915:Estrogen signaling pathway
NetPath Pathway FSH Signaling Pathway
EGFR1 Signaling Pathway
RANKL Signaling Pathway
Pathway Interaction Database Regulation of nuclear SMAD2/3 signaling
Signaling events mediated by HDAC Class II
Plasma membrane estrogen receptor signaling
LKB1 signaling events
Regulation of Telomerase
ATF-2 transcription factor network
AP-1 transcription factor network
FOXM1 transcription factor network
Validated nuclear estrogen receptor alpha network
Signaling mediated by p38-alpha and p38-beta
FOXA1 transcription factor networker_nongenomic_pathway:Plasma membrane estrogen receptor signaling
Validated nuclear estrogen receptor beta network
Reactome Nuclear signaling by ERBB4
Nuclear Receptor transcription pathwayR-HSA-383280:Nuclear Receptor transcription pathway
WikiPathways Estrogen signaling pathway
Nuclear Receptors Meta-Pathway
Estrogen Receptor Pathway
Signaling by ERBB4
JAK/STAT
Integrated Pancreatic Cancer Pathway
Leptin signaling pathway
miR-targeted genes in muscle cell - TarBase
Integrated Breast Cancer Pathway
Nuclear ReceptorsWP706:SIDS Susceptibility Pathways
Ovarian Infertility Genes
Nuclear Receptors
References
Ref 527584J Med Chem. 2005 Jun 16;48(12):3953-79.ERbeta ligands. 3. Exploiting two binding orientations of the 2-phenylnaphthalene scaffold to achieve ERbeta selectivity.
Ref 527584J Med Chem. 2005 Jun 16;48(12):3953-79.ERbeta ligands. 3. Exploiting two binding orientations of the 2-phenylnaphthalene scaffold to achieve ERbeta selectivity.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.